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Abstract: In the search for novel bioactive compounds from sponge-derived 
microorganisms, we have recently identified two structurally and biosynthetically 
unprecedented fungal metabolites, the novel-type alkaloids sorbicillactone A and 
sorbicillactone B. Sorbicillactone A is active against leukemia cells without showing 
notable cytotoxicity. Therefore, we have developed an efficient process for its 
biotechnological production and isolation on a large scale supplying sufficient material for 
the ongoing preclinical investigations and structure-activity relationship (SAR) studies. 
 
Keywords: sorbicillactone A, anti-leukemic activity, large-scale production, 
BIOTECmarin. 
 
Introduction 
In the course of a research program (“Molecular Biotechnology and Natural Products from Marine 
Sponges and Sponge-associated Microorganisms”) aiming at the discovery and characterization of 
novel natural products, we have identified the first members of a new class of secondary metabolites, 
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the sorbicillin-derived alkaloids sorbicillactone A (1) and its 2’,3’-dihydroanalog sorbicillactone B 
(2), from a salt-water culture of a Penicillium chrysogenum strain isolated from a specimen of the 
Mediterranean sponge Ircinia fasciculata [1,2]. These compounds originate via a likewise 
unprecedented biosynthetic pathway elucidated in our laboratories by applying feeding experiments 
with 13C-labelled precursors [2].  
 
 
Figure 1. Structures of sorbicillactones A (1) and B (2); the biosynthetic origins of the different 
molecular portions are shown in red (acetate), green (alanine), and blue (S-adenosylmethionine). 
Moreover, sorbicillactone A (1) exhibits a highly selective activity against the murine leukemic 
lymphoblast cell line L5178y, and has antiviral and neuroprotective properties [2,3]. Despite its 
almost identical molecular structure, 2 is significantly less active than 1 (by a factor of 10) [2,3]. Thus, 
for the complete evaluation of the therapeutical potential of 1, for preclinical investigations, and for 
SAR studies on semisynthetic analogs, a method for the large-scale production and isolation of the 
more promising derivative 1 was required, capable of eliminating the chromatographically almost 
identical analog 2 [4]. 
 
Results and Discussion 
Biotechnological Production of Sorbicillactone A (1) 
Sorbicillactone A (1) was first detected in a Penicillium chrysogenum isolate from the marine 
sponge Ircinia fasciculata (Porifera). The initial amounts produced were approximately 4 mg l-1 
(range 2-6 mg l-1) culture broth in surface liquid cultures. In order to increase the yield and to adapt 
the production to amounts sufficient for preclinical and clinical studies, growth media and culture 
conditions were varied. In parallel, screening experiments were performed to search for new strains 
with higher yields of 1. 
Growth experiments with surface cultures were performed in 300-ml Erlenmeyer flasks containing 
100 ml of medium while large-scale production was done with 700 ml medium in 2-l flasks. Cultures 
were inoculated with spore suspensions of Penicillium chrysogenum and incubated without shaking. 
The concentrations of 1 were measured by UV absorbance at 380 nm after separation by HPLC. 
Sorbicillactone A (1) was released to the culture medium but also accumulated in the mycelium of 
Penicillium chrysogenum. The mycelium was separated mechanically, by filtration, and 1 was 
extracted from the culture medium using XAD16. 
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Media Composition and Growth Conditions 
First experiments on the production of sorbicillactone A (1) were performed with Penicillium 
chrysogenum strain E01-10/3 in Wickerham medium (3.0 g yeast extract, 3.0 g malt extract, 5.0 g 
Bacto-peptone, and 10.0 g glucose in 1000 ml of sea water at 30 PSU and pH 7.3 [5]. The initial pH of 
the culture media had a significant influence on the production yield. Under acidic conditions (pH 4.0) 
production rates were very low (15% of maximum amounts) increasing to maximum values at pH 7.0. 
Temperature and salinity had interdependent influence on the production of 1 with optima at 28-30oC 
and 0.5-1.0% NaCl. NaCl exhibited a stronger effect and revealed higher production yields of 1 as 
compared to equivalent amounts of sea salts or marine water media. 
 
Production of the First 100 Grams of Substance 
In order to supply sufficient amounts of 1 for experiments on biochemical mechanisms, 
bioactivities, and toxicological studies, production was performed with strain E01-10/3 in modified 
Wickerham medium (Bacto-peptone 5.0 g, malt extract 3.0 g, yeast extract 3.0 g, glucose 10.0 g, and 
0.5 % NaCl, pH 6.6), resulting in yields of 25 mg l-1 culture broth on the average (ranges from 10-80 
mg l-1) after 14 days of incubation at 30oC in the dark.  
 
Improvement of the Culture Conditions 
Variations in the composition of complex nutrient components and single defined carbon substrates 
had measurable effects on the production of 1 by strain E01-10/3. Replacement of glucose in the basic 
Wickerham medium by other carbon sources (lactose, maltose, sucrose, fructose, galactose, trehalose, 
glycerol, pyruvate, acetate, or tri-sodium citrate) revealed different effects. Yields with all of these 
substrates were lower compared to those obtained with glucose. The highest yields were obtained with 
sucrose, galactose, maltose, and trehalose (approximately 60-66% compared to glucose). With lactose 
as a defined carbon source, the yield was reduced to less than 50% (as compared to the yield obtained 
with equal amounts of glucose) and was even lower with the other carbon sources.  
 
Preparation of Spore Suspension for Inoculation 
With some of the Penicillium chrysogenum strains experiments were performed to investigate the 
influence of the preparation method for spore suspensions on the production of 1 using spore 
suspension type 2 and type 3  for strains KIPB10, KIPB11, KIPB25, H269 and L122 and in addition 
type 1 for strain E01-10/3. It was found that the number of spores in the inoculum and the type of 
spore suspension had a significant influence on the formation of the surface mycelium and on the 
production of 1 (see Table 1). 
Type 1 spore suspensions were used for the mass cultivation in 2-l Erlenmeyer flasks. Spores were 
taken from agar plates, suspended in sterile sea water/glycerol 1/1 (v/v), and stored until use at -20°C. 
As inoculum, 100 µl of this suspension were used per 700-ml culture.  
Type 2 spore suspensions were taken from 2-week old agar cultures, suspended in 0.9% aqueous 
NaCl and directly used for inoculation.  
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For type 3 spore suspensions, spores were taken from 2-week old agar cultures and suspended in 
0.9% aqueous NaCl with 0.1% (w/v) Tween 80 immediately before inoculation into liquid cultures. 
Table 1. Sorbicillactone A production by strains of Penicillium chrysogenum isolated from various 
marine sources; * these isolates were kindly provided by Dr. K. Schaumann (AWI, Bremen) and now 
are included in the collection of marine fungi of the “Zentrum für Marine Wirkstoffe” in Kiel. 
Strain Source 
Quantity of 1 
produced Conditions of cultivation 
  [mg l-1 ]  
       
E01-10/3* Ircinia spec., Elba 25 Modified Wickerham medium (0.5% NaCl, pH 6.6) 
      (inoculated with spore suspension type 1) 
E01-10/3* Ircinia spec., Elba 102   
KIPB25 Tubulipora spec., Baltic Sea 99   
KIPB11 Tubulipora spec., Baltic Sea 97   
KIPB10 Tubulipora spec., Baltic Sea 96   
E99-2/174* Unidentified sponge, Elba 77   
E00-7/22* Hamigera hamigera, Elba 58   
E01-12/1* Ircinia spec., Elba 43   
R02-S2 marine sediment, Rovinj 26  Modified Wickerham medium, 0.5% NaCl, pH 7.0 
R02-S8 marine sediment, Rovinj 9  (inoculated with spore suspension type 2) 
H269 Halichondria panicea, Baltic Sea 9   
R03-9/5 Cacospongia scalaris, Rovinj 6   
H259 Halichondria panicea, Baltic Sea 5   
L122 Laminaria saccharina, Baltic Sea 5   
R02-13/2 Acanthella spec., Rovinj <1   
R03-8/4 Tethya aurantium, Rovinj <1   
H236 Halichondria panicea, Baltic Sea <1   
       
KIPB33 Callopora aurita, Baltic Sea 295   
E01-10/3* Ircinia spec., Elba 157   
KIPB25 Tubulipora spec., Baltic Sea 178   
KIPB11 Tubulipora spec., Baltic Sea 192 WSP medium (inoculated with spore  
KIPB10 Tubulipora spec., Baltic Sea 111 suspension type 3)  
H269 Halichondria panicea, Baltic Sea   11   
L122 Laminaria saccharina, Baltic Sea 17   
       
KIPB33 Callopora aurita, Baltic Sea 505 
Modified WSP medium (2.5 g glucose and 7.5 g 
lactose) 
   (inoculated with spore suspension type 3) 
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Screening for New Sorbicillactone A Producers 
During isolation procedures from various marine sources a number of additional strains of 
Penicillium chrysogenum (identified by morphological properties of colony, cells, and sporangia, and 
by 18S rDNA sequence comparison) were isolated. Some showed negligible production of 1, others 
provided highly improved production yields (see Table 1). New isolates of P. chrysogenum were 
obtained from marine sponges, bryozoans, algae, and also marine sediments from Baltic Sea and 
Mediterranean Sea habitats. The highest production yields of 1 were obtained with strains derived 
from bryozoans (KIPB10, KIPB11, KIPB25, and KIPB33). These phenotypic findings might indicate 
strain specific genetic differences, which result in various yields of 1. 
 
Selection and Improvement of Production of Sorbicillactone A (1) by Strain KIPB33 
By far the best yields were obtained with strain KIPB33 isolated from the bryozoan Callopora 
aurita from the Baltic Sea. If grown on WSP medium (modified Wickerham medium in which Bacto-
peptone was replaced by soybean peptone) yields were approximately two times higher as compared 
to strain E01-10/3 grown under identical conditions (100 ml in a 300-ml Erlenmeyer flask at 30°C). 
With this strain, experiments were performed in which glucose was replaced only partly by other 
carbon sources such that different ratios of glucose and the alternative carbon source were achieved in 
WSP medium. Further significant increases in yields of 1 were obtained with carbon mix B (5.0 g l-1 
glucose and 5.0 g l-1 lactose in modified WSP medium, 425 mg l-1 of 1) and with carbon mix C (2.5 g 
l-1 glucose and 7.5 g l-1 lactose in modified WSP medium, 505 mg l-1 of 1). 
 
Extraction of Sorbicillactone A (1) from the Culture Media 
After separation of the mycelia and filtration of the culture broth, 1 and other secondary 
metabolites were bound to XAD added directly to the culture broth (10 g XAD16 l-1) and eluted from 
the XAD with methanol. The methanol extracts were concentrated in a rotary evaporator and then 
used for further purification. 
 
Extraction of Sorbicillactone A (1) from the XAD Eluate 
For a first crude removal of large quantities of undesired major secondary metabolites of P. 
chrysogenum, such as, e.g., meleagrin, but also other water-soluble compounds like sugars and salts, a 
simple distribution of the XAD extract between water (pH = 7.0) and ethyl acetate proved highly 
efficient. After acidification of the remaining aqueous phase using phosphoric acid (pH = 2.0), 
compound 1 was quantitatively transferred into the organic phase (ethyl acetate) by renewed 
extraction. The extract thus obtained already contained ca. 50% (w/w) of sorbicillactone A (1). 
 
Purification of the Crude Extract by Fast Centrifugal Partition Chromatography (FCPC) 
To further purify the crude extract, the method of choice was FCPC [6] as a modern liquid-liquid 
chromatography, which, like High Speed Countercurrent Chromatography (HSCCC) [7], uses a 
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2-phase solvent system for separation. The ratio of the concentrations (K value) of a compound in the 
stationary and the mobile phase should be in the range of 0.7 to 4.5 to allow sufficient separation 
within acceptable retention times. To determine suitable solvent mixtures, 1 was distributed in 2-phase 
systems of different compositions, and the partitioning of the compound was determined using 
analytical HPLC. The best solvent mixture, with a K value of 1.04, consisted of n-heptane / ethyl 
acetate (42%/58%) as the stationary phase and methanol / water (42%/58%) as the mobile phase, both 
buffered with 0.1% phosphoric acid. When using a 200-ml rotor at a constant flow of 7 ml min-1 at 
1200 rpm, the purification of 1.5 g of extract per run was possible, each run needing approximately 
90 min including flushing and equilibration of the chromatographic system [8]. After evaporation of 
the organic solvents of the fractions containing sorbicillactone A (1), the remaining aqueous solution 
was exhaustively extracted with ethyl acetate. The resulting extracts almost exclusively contained 1 
and 2 in their natural ratio as obtained after fermentation, i.e., with up to ca. 70% (w/w) sorbicillactone 
A (1). 
 
Resolution of 1 and 2 by Gel Chromatography on Sephadex LH20 
The most demanding step during the isolation process of sorbicillactone A (1) was its separation 
from the structurally – and thus chromatographically – almost identical 2’,3’-dihydroanalog, 
sorbicillactone B (2). The resolution succeeded by gel chromatography on Sephadex LH-20 [9], albeit 
only when using a long chromatographic system (6-m column, 3.5 cm inner diameter) and pure 
methanol as the eluent. The solvent was pumped through the column by using an MPLC pump at a 
constant flow rate of 10 ml min-1. For a single run 1.5 g of the extracts derived from the FCPC 
separation were dissolved in 7 ml of methanol and loaded over an 8-ml injection loop. Sorbicillactone 
B (2) was eluted after ca. 7 h, directly followed by sorbicillactone A (1). Although the two compounds 
were not baseline separated, ca. 70% of 1 submitted to the gel chromatography was recovered in pure 
fractions after the column. The remaining 30% of 1 were still contaminated with 2, but were easily 
further purified by renewed chromatography. 
 
Analysis of the Purity of Sorbicillactone A (1) Containing Fractions 
For a fast analysis of the purity of the fractions obtained after the chromatographic steps, a variety 
of HPLC methods were tested. Initially, the quality of the fractions was checked by using a Waters 
Symmetry C18 column (2.1 x 150 mm, 0.4 ml min-1 flow) with an isocratic solvent system (water / 
acetonitrile / TFA = 70/30/0.05; elution time for 1: 12.5 min, and for 2: 13.2 min). These analyses 
required 23 min per run (including flushing and conditioning of the column), thus consuming too 
much time for the analysis of a large number of fractions. The time per sample was significantly 
reduced to 5 min by utilizing a Merck Chromolith column (4.6 x 100 mm) using the same solvent 
system as described above, but at a flow rate of 5 ml min-1.  
To further reduce the analysis time needed per fraction of the final gel chromatography and to 
avoid the use of HPLC systems for these experiments, an additional method for the validation of the 
purity of these samples was developed, by taking advantage of the different UV properties of 1 and 2, 
which both significantly absorb at 300 nm (Fig. 2, blue bars, corresponding to the overall 
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concentrations of 1 plus 2), but only 1 is UV active at 430 nm (Fig. 2, green bars, proportional to the 
concentration of 1, only). Thus, when showing a constant ratio between the measurement of the UV 
absorption at 300 nm and at 430 nm of a certain fraction (Fig. 2, red bars, from fractions 9 to 17), the 
sample exclusively contained the more slowly eluting pure sorbicillactone A (1). By applying this 
method, the time required for analysis of the resolved fractions was drastically reduced to below 1 
minute. 
 
 
Figure 2. Rapid analysis of the sorbicillactone A/B ratio by UV measurements. The blue and green 
bars show the relative absorbance of the fractions at 300 nm and 430 nm, respectively, while the red 
bars correspond to the ratios of the two absorbances. 
Conclusions 
A method for the biotechnological production of large quantities of the antileukemic marine 
compound sorbicillactone A (1) was developed. By this procedure, 100 g of pure sorbicillactone A (1) 
have been isolated for ongoing preclinical studies on this potential antitumoral drug, despite the 
demanding separation problem due to the co-occurrence of sorbicillactone B (2). Although significant 
production of 1 by Penicillium chrysogenum only succeeded in static surface cultures of the fungus, 
the dramatically increased yield by strain selection and the systematic variation of culture conditions 
now permits biotechnological production of kilogram quantities of 1, sufficient for clinical trials. 
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